These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2569478)
1. Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies. Poon MC; Russell JA; Low S; Sinclair GD; Jones AR; Blahey W; Ruether BA; Hoar DI J Clin Invest; 1989 Sep; 84(3):787-92. PubMed ID: 2569478 [TBL] [Abstract][Full Text] [Related]
2. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation. Wölpl A; Lattke H; Board PG; Arnold R; Schmeiser T; Kubanek B; Robin-Winn M; Pichelmayr R; Goldmann SF Transplantation; 1987 Jan; 43(1):151-3. PubMed ID: 3541316 [TBL] [Abstract][Full Text] [Related]
3. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756 [TBL] [Abstract][Full Text] [Related]
4. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation. Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519 [TBL] [Abstract][Full Text] [Related]
5. Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia. Mehta J; Powles R; Horton C; Treleaven J; Singhal S Bone Marrow Transplant; 1996 Aug; 18(2):319-24. PubMed ID: 8864441 [TBL] [Abstract][Full Text] [Related]
6. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose. Keever-Taylor CA; Klein JP; Eastwood D; Bredeson C; Margolis DA; Burns WH; Vesole DH Bone Marrow Transplant; 2001 Apr; 27(8):791-800. PubMed ID: 11477435 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338 [TBL] [Abstract][Full Text] [Related]
8. Hemopoietic reconstitution after bone marrow transplantation. Arnold R; Schmeiser T; Heit W; Frickhofen N; Pabst G; Heimpel H; Kubanek B Exp Hematol; 1986 May; 14(4):271-7. PubMed ID: 2870935 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis. Iversen PO; Wiig H Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766 [TBL] [Abstract][Full Text] [Related]
10. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity. Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817 [TBL] [Abstract][Full Text] [Related]
12. Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation. Michur H; Maślanka K; Szczepiński A; Mariańska B Int J Lab Hematol; 2008 Dec; 30(6):519-25. PubMed ID: 18983304 [TBL] [Abstract][Full Text] [Related]
13. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation]. Sawada H; Wake A; Yamasaki Y; Izumi Y Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350 [TBL] [Abstract][Full Text] [Related]
14. Factor XIII in human plasma and platelets. McDonagh J; McDonagh RP; Delâge JM; Wagner RH J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors. Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376 [TBL] [Abstract][Full Text] [Related]
16. Factor XIII of blood coagulation as a nuclear crosslinking enzyme. Adány R; Bárdos H; Antal M; Módis L; Sárváry A; Szücs S; Balogh I Thromb Haemost; 2001 May; 85(5):845-51. PubMed ID: 11372678 [TBL] [Abstract][Full Text] [Related]
17. Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery. Van der Lely N; De Witte T; Raemaekers J; Schattenberg A; Haanen C Bone Marrow Transplant; 1989 Mar; 4(2):163-6. PubMed ID: 2650786 [TBL] [Abstract][Full Text] [Related]
18. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Siebenlist KR; Meh DA; Mosesson MW Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711 [TBL] [Abstract][Full Text] [Related]
19. [Estimation of megakaryothrombopoiesis by mean platelet volume in leukemia patients during the course of chemotherapy and patients undergoing bone marrow transplantation]. Gondo K; Miyachi H; Tanaka Y; Kawada T; Kato S; Arimori S; Ando Y Rinsho Ketsueki; 1993 Jul; 34(7):835-41. PubMed ID: 8360987 [TBL] [Abstract][Full Text] [Related]
20. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]